Anavex Life Sciences Corp. AVXL
NASDAQ · United States · Health Technology
$1.82-0.07 (-3.70%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q3 2026 | 2026-08-25 | 0.08 | -0.08 | +200.0% | +4.2%$3.11→$3.24 |
| Q2 2026 | 2026-07-30 | -0.06 | -0.07 | +14.3% | +10.4%$2.49→$2.75 |
| Q1 2026 | 2026-02-09 | -0.06 | -0.11 | +45.5% | -3.4%$4.10→$3.96 |
| Q4 2025 | 2025-11-25 | -0.11 | -0.15 | +26.7% | +25.3%$3.08→$3.86 |
| Q3 2025 | 2025-08-12 | -0.16 | -0.14 | -14.3% | — |
| Q2 2025 | 2025-05-13 | -0.13 | -0.15 | +13.3% | — |
| Q1 2025 | 2025-02-12 | -0.14 | -0.17 | +17.6% | — |
| Q4 2024 | 2024-12-23 | -0.14 | -0.17 | +17.6% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.